0001493152-19-002123.txt : 20190214 0001493152-19-002123.hdr.sgml : 20190214 20190214171520 ACCESSION NUMBER: 0001493152-19-002123 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190214 FILED AS OF DATE: 20190214 DATE AS OF CHANGE: 20190214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zhivilo Yury CENTRAL INDEX KEY: 0001730089 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38325 FILM NUMBER: 19608263 MAIL ADDRESS: STREET 1: 70 DOPPLER CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Hancock Jaffe Laboratories, Inc. CENTRAL INDEX KEY: 0001661053 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330936180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 70 DOPPLER CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-261-2900 MAIL ADDRESS: STREET 1: 70 DOPPLER CITY: IRVINE STATE: CA ZIP: 92618 3/A 1 ownership.xml X0206 3/A 2019-02-14 2018-05-30 0 0001661053 Hancock Jaffe Laboratories, Inc. HJLI 0001730089 Zhivilo Yury 13 RUE DE LA GARE 1100 MORGES V8 1110 SWITZERLAND 1 0 1 0 Common Stock 4443569 I By Biodyne Holding, S.A. Common Stock 35012 I By Leman Cardiovascular, S.A. Reflects a 1-for-2 reverse stock split of the Issuer's common stock effected on December 14, 2017. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. This amendment to Form 3 is being filed by the reporting person to correct the number of shares held by Biodyne Holding, S.A. on the initial reporting date. /s/ Yury Zhivilo 2019-02-14